An unremitting trend of lower spending by large pharmaceutical customers in North America hurt Waters’ sales in the second quarter, but strong sales in Asia pushed the firm’s overall revenues up 6 percent year over year to $302 million, the company said this week.
 
A depressed pharmaceutical spending market has been a common refrain from Waters officials over the past five quarters, but while they believe the decline has bottomed out they are maintaining a conservative outlook.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

This year's Breakthrough Prize winners include a pair that developed a therapy for spinal muscular atrophy.

The New York Times reports on how white supremacists misconstrue genetic research, concerning many geneticists.

Researchers find that people's genetics influence their success at university, but that it is not the only factor.

In Nature this week: approach to identify genetic variants that affect trait variability, application of read clouds to microbiome samples, and more.